German Pharma Stock News

XTRA:SAP
XTRA:SAPSoftware

Do SAP’s New AI Partnerships Strengthen or Complicate Its Cloud Story (XTRA:SAP)?

In March 2026, LatticeFlow AI and Prismforce each announced partnerships with SAP, bringing AI risk-governance and workforce-skill platforms onto SAP Store and integrating tightly with SAP’s cloud HR and application ecosystems. These collaborations highlight how SAP’s partner network is embedding advanced AI compliance and skills intelligence directly into its software stack, even as analysts reassess the strength and predictability of its cloud business. Next, we’ll examine how JPMorgan’s...
XTRA:LXS
XTRA:LXSChemicals

Is LANXESS (XTRA:LXS) Now Attractive After Its Recent Share Price Volatility

If you are wondering whether LANXESS at around €17.02 is a bargain or a value trap, this article will walk you through what the current share price might be implying. The stock has been volatile, with a 44.0% return over the last 7 days, set against a 12.1% decline over 30 days and a 42.2% decline over the past year. Recent coverage has focused on LANXESS as a chemicals group under pressure, including commentary on its share price weakness over multi year periods and the challenges this can...
XTRA:FRE
XTRA:FREHealthcare

Fresenius SE KGaA (XTRA:FRE) Margin Rebound Tests Long Term Earnings Skepticism

Fresenius SE KGaA (XTRA:FRE) has just wrapped up FY 2025 with fourth quarter revenue of €5.96b and basic EPS of €0.70, capping off a trailing twelve month run where revenue reached €22.45b and EPS came in at €1.94 by the end of Q3 2025, alongside earnings growth of 25.2% over the last year. Over recent periods the company has seen revenue move from €21.48b in the twelve months to Q3 2024 to €22.45b in the twelve months to Q3 2025, while EPS over the same stretch went from €1.55 to €1.94. This...
XTRA:DHER
XTRA:DHERHospitality

Delivery Hero (XTRA:DHER) EPS Loss Narrows Yet Again And Tests Bearish Profitability Narratives

Delivery Hero (XTRA:DHER) has reported first half FY 2025 revenue of €6.9b with a basic EPS loss of €1.34, while trailing 12 month revenue stands at €13.4b and EPS at a loss of €1.91. Over recent periods the company has seen revenue move from €5.8b and a basic EPS loss of €2.58 in the first half of 2024 to €6.5b and a basic EPS loss of €0.57 in the second half of 2024. This provides useful context for how the latest numbers fit into its ongoing push toward smaller losses. For investors, the...
XTRA:HEN3
XTRA:HEN3Household Products

Henkel KGaA (XTRA:HEN3) Valuation Check After New R&D Center Plan And Sustainability Financing Update

Henkel KGaA (XTRA:HEN3) is back on investor radars after two ESG related financing updates, including a margin step up on its €650,000,000 sustainability linked notes and a separate €10b bond issuance program. See our latest analysis for Henkel KGaA. Recent ESG financing news and the €10b bond program come as Henkel KGaA's 7 day share price return of 2.29% contrasts with a 30 day share price decline of 19.20% and a 1 year total shareholder return of 5.85% loss. This hints at fading short term...
XTRA:FME
XTRA:FMEHealthcare

Fresenius Medical Care (XTRA:FME) Valuation Check After Recent Share Price Reset

Fresenius Medical Care (XTRA:FME) is back in focus after a recent share move, with the stock closing at €38.40 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Fresenius Medical Care. That latest move to €38.40 comes after a 7.22% 1 month share price decline and a 4.41% year to date share price pullback. The 1 year total shareholder return of a 12.80% decline contrasts with a 3 year total shareholder return of a 9.34% gain. If this kind of...
XTRA:BNR
XTRA:BNRTrade Distributors

Brenntag (XTRA:BNR) Valuation Tested After Q4 Sales Slump And Swing To Net Loss

Fourth quarter results put Brenntag (XTRA:BNR) under closer scrutiny Brenntag (XTRA:BNR) moved into focus after fourth quarter 2025 earnings showed sales of €3,512 million compared with €3,989.7 million a year earlier, and a net loss of €23.5 million replacing prior net income. See our latest analysis for Brenntag. The latest quarterly loss has sharpened attention on Brenntag, yet the share price has recently moved higher, with a 7 day share price return of 13.86% and a 90 day share price...
XTRA:NDX1
XTRA:NDX1Electrical

A Look At Nordex (XTRA:NDX1) Valuation After A Wave Of New Wind Turbine Orders

Why Nordex stock is drawing attention after a wave of new orders Nordex (XTRA:NDX1) has been in focus after a series of new turbine orders in Germany and Serbia, including projects with Prowind, repowering work on Fehmarn island, and a community wind farm in North Rhine-Westphalia. See our latest analysis for Nordex. These new German and Serbian orders have arrived alongside strong market interest, with the share price at €45.4 and a 30 day share price return of 34.8%, while the 1 year total...
XTRA:BAS
XTRA:BASChemicals

Is BASF (XTRA:BAS) Pricing Look Attractive After Recent Share Price Rebound?

If you are asking yourself whether BASF at €50.02 is offering value or just fair pricing, this breakdown is for you. The stock has returned 3.6% over the last 7 days, 2.4% over the last 30 days, 11.7% year to date, and 6.0% over the last year. This gives you a useful snapshot of how sentiment has shifted over different time frames. Recent headlines around BASF have focused on broader sector conditions and how large chemicals groups are positioning their portfolios and cost bases. These...
XTRA:LXS
XTRA:LXSChemicals

A Look At LANXESS (XTRA:LXS) Valuation After A Steep Share Price Reset

LANXESS stock at a glance LANXESS (XTRA:LXS) has been drawing attention after a recent stretch of weak share performance, including negative returns over the past month, past 3 months, and year. This has prompted fresh questions about how investors view the specialty chemicals group. See our latest analysis for LANXESS. At around €13.95, LANXESS has seen a sharp 30-day share price return of about a 29% decline and a 1-year total shareholder return of roughly a 54% loss, which points to fading...
XTRA:SDF
XTRA:SDFChemicals

Assessing K+S (XTRA:SDF) Valuation After 2025 Net Loss And Dividend Cut

Earnings shock and reduced dividend put K+S (XTRA:SDF) under closer investor scrutiny K+S (XTRA:SDF) has come under pressure after reporting a full year 2025 net loss of €1,075.8 million and confirming a sharply reduced annual dividend of €0.07 per share. The results included sales of €3,647.9 million and a basic loss per share from continuing operations of €6.01. This has set the context for reassessing the stock and its income appeal ahead of the May 2026 payout. See our latest analysis for...
XTRA:SZG
XTRA:SZGMetals and Mining

Salzgitter Restructuring And Green Steel Funding Raise Questions On Valuation

Salzgitter AG has completed a major restructuring that returned its trading business to profitability and exceeded internal cost saving targets. The company secured additional funding for its SALCOS green steel program, bringing total backing for the project to €1.3b. Salzgitter AG rejoined the MDAX index, highlighting its renewed relevance for German mid cap investors. Salzgitter (XTRA:SZG) is entering this phase of change with a share price of €37.28 and a mixed return profile. The stock...
XTRA:BOSS
XTRA:BOSSLuxury

Hugo Boss Cuts Air Freight And Tightens Range To Refine Profit Story

Hugo Boss plans to phase out regular use of air freight to cut costs and reduce its environmental footprint. The company is also working to streamline its product assortment to sharpen brand focus. These operational changes are being assessed by investors alongside the current share price of €36.78 for XTRA:BOSS. XTRA:BOSS is trading at €36.78, with a 1 year return of 5.8% and a 3 year return showing a 36.2% decline. The mixed track record over recent years means operational moves like...
XTRA:ADS
XTRA:ADSLuxury

Is adidas (XTRA:ADS) Now Offering Opportunity After A 40% One Year Share Price Slump?

If you are wondering whether adidas at €133.05 is a bargain or a value trap, this breakdown will help you frame the current share price against what the business might be worth. Over the short and medium term, the stock has seen returns of 5.4% decline over 7 days, 16.2% decline over 30 days, 20.5% decline year to date, and 40.1% decline over 1 year, which may have shifted how the market is thinking about its risk and potential. Recent coverage has focused on adidas as a major global...
XTRA:VOW3
XTRA:VOW3Auto

Does Volkswagen’s Job Cuts and Tech Pivot Reshape the Bull Case For Volkswagen (XTRA:VOW3)?

Volkswagen AG previously announced it will pay an annual dividend of €5.26 per share on June 23, 2026, while pressing ahead with extensive restructuring and plans to cut about 50,000 jobs in Germany by 2030 to address high labor and energy costs and improve manufacturing productivity. At the same time, Volkswagen is reinforcing its push into software and data-driven services through a new fleet-data partnership with OCTO and expanding its electric SUV line-up in China with XPeng,...
XTRA:BAS
XTRA:BASChemicals

BASF’s Canola R&D Push and Dividend Steadiness Might Change The Case For Investing In BASF (XTRA:BAS)

BASF SE has affirmed an annual dividend of €2.25 per share payable on May 6, 2026, and earlier this month committed C$27 million to expand and modernise its Canola Breeding Centre of Innovation in Saskatoon with advanced automation and precision-controlled growth facilities. This investment underlines BASF’s push to strengthen its agricultural solutions franchise through faster development of new canola hybrids and enhanced research capabilities that support growers in North America, Europe...
XTRA:VNA
XTRA:VNAReal Estate

Vonovia (XTRA:VNA) Valuation Check After Swing Back To €3,723m Net Income In 2025 Results

Why Vonovia’s 2025 earnings are drawing fresh attention Vonovia (XTRA:VNA) has moved back into the spotlight after reporting full year 2025 earnings, shifting from a prior net loss to net income of €3,723 million and positive earnings per share. See our latest analysis for Vonovia. Despite the swing back to profit, the share price has fallen recently. It has a 7 day share price return of 14.8% and a 30 day share price return of 23.5%, while the 3 year total shareholder return of 42.4%...
XTRA:SAP
XTRA:SAPSoftware

A Look At SAP (XTRA:SAP) Valuation After Recent Share Price Weakness

SAP (XTRA:SAP) has drawn attention after a period of weak share performance, with the stock showing negative returns over the past month and past 3 months. This has prompted investors to reassess the software group’s fundamentals. See our latest analysis for SAP. At a share price of €153.86, SAP’s recent share price return shows a 7 day decline of 7.01% and a 30 day drop of 11.47%. The 1 year total shareholder return of a 39.20% decline contrasts with positive 3 and 5 year total shareholder...
XTRA:DBK
XTRA:DBKCapital Markets

Does Deutsche Bank’s Leadership Shuffle and Funding Strategy Shift Change The Bull Case For Deutsche Bank (XTRA:DBK)?

In March 2026, Deutsche Bank announced multiple Management Board and Group Management Committee changes, including elevating DWS CEO Stefan Hoops to the Group board, appointing Marie-Jeanne Deverdun as Chief Technology, Data and Innovation Officer, and naming Fabrizio Campelli as President, while also continuing to raise long-dated, callable senior unsecured fixed-rate funding through a series of US dollar and euro bond offerings. Taken together with disclosures about very large private...